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Background：Malaria, one of the most important parasitic infectious diseases for which 
almost half of the world’s population is at risk is caused by Plasmodium spp. There is still a 
need of highly sensitive diagnostics for its detection in endemic field. The loop-mediated 
isothermal amplification (LAMP) method is a DNA amplification tool in which the DNA 
amplification can be achieved by incubation at a stable temperature. A malaria detection kit 
based on this methodology has shown promising results in previous studies. This thesis aimed 
at evaluating this method as part of a field-friendly system, using DNA extracted from dried 
blood spots by a simple DNA extraction method, the procedure for ultra rapid extraction 
(PURE), which can produce a DNA solution suitable for the LAMP reaction without the use 
of a centrifuge. 
Hypothesizing that this method is more sensitive than microscopy, another objective was to 
estimate the proportion of antimalarial resistant isolates that are found among submicroscopic 
infections detected by PURE-LAMP. 
 
Methods：Blood samples were tested by a rapid diagnostic test (BinaxNow® Malaria, Alere 
Inc., Waltham, MA, USA), microscopy, PURE-LAMP and nested PCR. The sensitivity and 
specificity of each method were estimated with nested PCR as gold standard. The analysis was 
conducted retrospectively with samples collected from 2011 to 2016 at the National Center for 
Global Health and Medicine in Tokyo. 
The PURE-LAMP was subsequently applied as a screening method in a malaria endemic 
country, Haiti. PURE-LAMP positive samples were targeted for genotyping of resistance 
markers for 2 antimalarial drugs: chloroquine and artemisinin. PURE-LAMP as a screening 
method was further compared to microscopy and rapid diagnostic test (SD Bioline Malaria Ag 
Pf/ Pan; Standard Diagnostics, Inc., Suwon, South Korea). 
 
 
Results：One hundred and seventeen samples including 46 Plasmodium falciparum, 7 P. 
vivax, 9 P. ovale, 4 P. malariae, and 51 negative cases were tested. The PURE–LAMP Pan 
(targeting Plasmodium genus) correctly identified 64 of the 66 positives and the 51 negatives. 
Among the Pan-positive samples 45 P. falciparum were also detected with the PURE–LAMP 
Pf (targeting P. falciparum specifically). The PURE–LAMP Pan and PURE–LAMP Pf had 
respective sensitivities of 96.96% (95% CI 89.47–99.63) and 97.82% (95% CI 88.47–99.94) 
and common specificity of 100%.  
During the field survey in Haiti, among 98 samples detected positive by PURE-LAMP Pf, 89 
samples were successfully sequenced for P. falciparum chloroquine resistance transporter, a 
chloroquine resistance marker and 85 samples were successfully sequenced for kelch 13, an 
artemisinin resistance marker. Rapid diagnostic test and microscopy detected 76 and 44 
respectively of those analyzed positive samples. All samples presented sensitive phenotypes. 
 
Discussion and Conclusion: The obtained sensitivity and specificity by the retrospective study 
were as expected based on previous publications, showing that the Loopamp kit still performs 
well with DNA extracted by the PURE method from dried blood spots. In the endemic field, it 
allowed detection of infections (symptomatic or not) missed by light microscopy or rapid 
diagnostic test. Thus, this system (PURE-LAMP malaria on dried blood spots) is a valuable 
tool for malaria mass screening. 
The proportions of resistant genotypes from microscopic or submicroscopic infections could 
not be estimated as all sequenced samples presented the sensitive genotype. No drug 
resistance-associated mutation was detected in P. falciparum chloroquine resistance transporter 
nor in kelch 13 of the isolates from Haiti. This confirms chloroquine as the drug of choice for 
treatment of uncomplicated malaria in Haiti, unlike the global trend for treatment of P. 
falciparum infection, and artemisinin as a valid alternative. The contribution of submicroscopic 
infections to the resistant parasites pool is still needed to be studied elsewhere. 
